-
1
-
-
28844480321
-
Management of hepatocellular carcinoma
-
Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-36.
-
(2005)
Hepatology
, vol.42
, pp. 1208-1236
-
-
Bruix, J.1
Sherman, M.2
-
2
-
-
79952231921
-
Management of hepatocellular carcinoma: An update
-
Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011;53:1020-2.
-
(2011)
Hepatology
, vol.53
, pp. 1020-1022
-
-
Bruix, J.1
Sherman, M.2
-
3
-
-
84871842819
-
Recent advances in CT and MR imaging for evaluation of hepatocellular carcinoma
-
Lee J, Yoon JH, Joo I, Woo H. Recent advances in CT andMR imaging for evaluation of hepatocellular carcinoma. Liver Cancer 2012;1: 22-40.
-
(2012)
Liver Cancer
, vol.1
, pp. 22-40
-
-
Lee, J.1
Yoon, J.H.2
Joo, I.3
Woo, H.4
-
4
-
-
54349111702
-
Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: A systematic review and meta-analysis
-
Silva MA, Hegab B, Hyde C, Guo B, Buckels JA, Mirza DF. Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis. Gut 2008;57: 1592-6.
-
(2008)
Gut
, vol.57
, pp. 1592-1596
-
-
Silva, M.A.1
Hegab, B.2
Hyde, C.3
Guo, B.4
Buckels, J.A.5
Mirza, D.F.6
-
5
-
-
34548254899
-
Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC
-
Stigliano R, Marelli L, Yu D, Davies N, Patch D, Burroughs AK. Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev 2007;33: 437-47.
-
(2007)
Cancer Treat Rev
, vol.33
, pp. 437-447
-
-
Stigliano, R.1
Marelli, L.2
Yu, D.3
Davies, N.4
Patch, D.5
Burroughs, A.K.6
-
6
-
-
0035128185
-
Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: A cost effectiveness analysis
-
Bolondi L, Sofia S, Siringo S, Gaiani S, Casali A, Zironi G, et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 2001;48:251-9.
-
(2001)
Gut
, vol.48
, pp. 251-259
-
-
Bolondi, L.1
Sofia, S.2
Siringo, S.3
Gaiani, S.4
Casali, A.5
Zironi, G.6
-
7
-
-
0035143887
-
The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma
-
Johnson PJ. The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma. Clin Liver Dis 2001;5:145-59.
-
(2001)
Clin Liver Dis
, vol.5
, pp. 145-159
-
-
Johnson, P.J.1
-
8
-
-
79952230973
-
Alpha-fetoprotein should be included in the hepatocellular carcinoma surveillance guidelines of the American Association for the Study of Liver Diseases
-
author reply 1-2
-
Marrero JA, El-Serag HB. Alpha-fetoprotein should be included in the hepatocellular carcinoma surveillance guidelines of the American Association for the Study of Liver Diseases. Hepatology 2011;53: 1060-1; author reply 1-2.
-
(2011)
Hepatology
, vol.53
, pp. 1060-1061
-
-
Marrero, J.A.1
El-Serag, H.B.2
-
9
-
-
0035056663
-
Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: Influence of HBsAg and anti-HCV status
-
Trevisani F, D'Intino PE, Morselli-Labate AM, Mazzella G, Accogli E, Caraceni P, et al. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: Influence of HBsAg and anti-HCV status. J Hepatol 2001;34:570-5.
-
(2001)
J Hepatol
, vol.34
, pp. 570-575
-
-
Trevisani, F.1
D'Intino, P.E.2
Morselli-Labate, A.M.3
Mazzella, G.4
Accogli, E.5
Caraceni, P.6
-
10
-
-
0024306506
-
Isolation and characterization of a hepatoma-associated abnormal (des-gamma-carboxy)prothrombin
-
Liebman HA. Isolation and characterization of a hepatoma-associated abnormal (des-gamma-carboxy)prothrombin. Cancer Res 1989;49: 6493-7.
-
(1989)
Cancer Res
, vol.49
, pp. 6493-6497
-
-
Liebman, H.A.1
-
11
-
-
0036215258
-
Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: A prospective study
-
Ikoma J, Kaito M, Ishihara T, Nakagawa N, Kamei A, Fujita N, et al. Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: a prospective study. Hepatogastroenterology 2002;49:235-8.
-
(2002)
Hepatogastroenterology
, vol.49
, pp. 235-238
-
-
Ikoma, J.1
Kaito, M.2
Ishihara, T.3
Nakagawa, N.4
Kamei, A.5
Fujita, N.6
-
12
-
-
80053158728
-
Highly sensitive lens culinaris agglutinin-reactive alpha-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease
-
Oda K, Ido A, Tamai T, Matsushita M, Kumagai K, Mawatari S, et al. Highly sensitive lens culinaris agglutinin-reactive alpha-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease. Oncol Rep 2011;26:1227-33.
-
(2011)
Oncol Rep
, vol.26
, pp. 1227-1233
-
-
Oda, K.1
Ido, A.2
Tamai, T.3
Matsushita, M.4
Kumagai, K.5
Mawatari, S.6
-
13
-
-
84855306790
-
Highly sensitive lens culinaris agglutininreactive alpha-fetoprotein: A new tool for the management of hepatocellular carcinoma
-
Toyoda H, Kumada T, Tada T. Highly sensitive lens culinaris agglutininreactive alpha-fetoprotein: a new tool for the management of hepatocellular carcinoma. Oncology 2011;81 Suppl 1:61-5.
-
(2011)
Oncology
, vol.81
, Issue.SUPPL. 1
, pp. 61-65
-
-
Toyoda, H.1
Kumada, T.2
Tada, T.3
-
14
-
-
84874630856
-
Toward a standardized system for hepatocellular carcinoma diagnosis using computed tomography and MRI
-
Tang A, Cruite I, Sirlin CB. Toward a standardized system for hepatocellular carcinoma diagnosis using computed tomography and MRI. Expert Rev Gastroenterol Hepatol 2013;7:269-79.
-
(2013)
Expert Rev Gastroenterol Hepatol
, vol.7
, pp. 269-279
-
-
Tang, A.1
Cruite, I.2
Sirlin, C.B.3
-
15
-
-
0034122117
-
Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation
-
Gambarin-Gelwan M, Wolf DC, Shapiro R, Schwartz ME, Min AD. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation. Am J Gastroenterol 2000;95:1535-8.
-
(2000)
Am J Gastroenterol
, vol.95
, pp. 1535-1538
-
-
Gambarin-Gelwan, M.1
Wolf, D.C.2
Shapiro, R.3
Schwartz, M.E.4
Min, A.D.5
-
16
-
-
0036712048
-
Focal lesions in cirrhotic explant livers: Pathological evaluation and accuracy of pretransplantation imaging examinations
-
Libbrecht L, Bielen D, Verslype C, Vanbeckevoort D, Pirenne J, Nevens F, et al. Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations. Liver Transpl 2002;8:749-61.
-
(2002)
Liver Transpl
, vol.8
, pp. 749-761
-
-
Libbrecht, L.1
Bielen, D.2
Verslype, C.3
Vanbeckevoort, D.4
Pirenne, J.5
Nevens, F.6
-
17
-
-
0037293402
-
Detection of primary hepatic malignancy in liver transplant candidates: Prospective comparison of CT, MR imaging, US, and PET
-
Teefey SA, Hildeboldt CC, Dehdashti F, Siegel BA, Peters MG, Heiken JP, et al. Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT,MRimaging, US, and PET. Radiology 2003;226:533-42.
-
(2003)
Radiology
, vol.226
, pp. 533-542
-
-
Teefey, S.A.1
Hildeboldt, C.C.2
Dehdashti, F.3
Siegel, B.A.4
Peters, M.G.5
Heiken, J.P.6
-
18
-
-
0035722375
-
Surveillance for hepatocellular carcinoma in patientswith chronic viral hepatitis in the United States of America
-
Tong MJ, Blatt LM, Kao VW. Surveillance for hepatocellular carcinoma in patientswith chronic viral hepatitis in the United States of America. J Gastroenterol Hepatol 2001;16:553-9.
-
(2001)
J Gastroenterol Hepatol
, vol.16
, pp. 553-559
-
-
Tong, M.J.1
Blatt, L.M.2
Kao, V.W.3
-
19
-
-
0034991518
-
Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival
-
Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001;33:1394-403.
-
(2001)
Hepatology
, vol.33
, pp. 1394-1403
-
-
Yao, F.Y.1
Ferrell, L.2
Bass, N.M.3
Watson, J.J.4
Bacchetti, P.5
Venook, A.6
-
20
-
-
78751702512
-
CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis
-
Yu NC, Chaudhari V, Raman SS, Lassman C, Tong MJ, Busuttil RW, et al. CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis. Clin Gastroenterol Hepatol 2011;9:161-7.
-
(2011)
Clin Gastroenterol Hepatol
, vol.9
, pp. 161-167
-
-
Yu, N.C.1
Chaudhari, V.2
Raman, S.S.3
Lassman, C.4
Tong, M.J.5
Busuttil, R.W.6
-
21
-
-
79958185773
-
Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA
-
El-Serag HB, Kramer JR, Chen GJ, Duan Z, Richardson PA, Davila JA. Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA. Gut 2011;60:992-7.
-
(2011)
Gut
, vol.60
, pp. 992-997
-
-
El-Serag, H.B.1
Kramer, J.R.2
Chen, G.J.3
Duan, Z.4
Richardson, P.A.5
Davila, J.A.6
-
22
-
-
67449107459
-
Metaanalysis: Surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis
-
Singal A, Volk M, Waljee A, Salgia R, Higgins P, Rogers M, et al. Metaanalysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. Aliment Pharmacol Ther 2009;30: 37-47.
-
(2009)
Aliment Pharmacol Ther
, vol.30
, pp. 37-47
-
-
Singal, A.1
Volk, M.2
Waljee, A.3
Salgia, R.4
Higgins, P.5
Rogers, M.6
-
23
-
-
23844534811
-
Reporting recommendations for tumor marker prognostic studies (REMARK)
-
McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst 2005;97:1180-4.
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 1180-1184
-
-
McShane, L.M.1
Altman, D.G.2
Sauerbrei, W.3
Taube, S.E.4
Gion, M.5
Clark, G.M.6
-
24
-
-
33644553034
-
Standards for reporting prognostic tumor marker studies
-
Alonzo TA. Standards for reporting prognostic tumor marker studies. J Clin Oncol 2005;23:9053-4.
-
(2005)
J Clin Oncol
, vol.23
, pp. 9053-9054
-
-
Alonzo, T.A.1
-
25
-
-
48549106668
-
AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease
-
Beale G, Chattopadhyay D, Gray J, Stewart S, Hudson M, Day C, et al. AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease. BMC Cancer 2008;8:200.
-
(2008)
BMC Cancer
, vol.8
, pp. 200
-
-
Beale, G.1
Chattopadhyay, D.2
Gray, J.3
Stewart, S.4
Hudson, M.5
Day, C.6
-
26
-
-
0003809054
-
-
New York: Springer
-
Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, et al. AJCC cancer staging manual. New York: Springer; 2002.
-
(2002)
AJCC Cancer Staging Manual
-
-
Greene, F.L.1
Page, D.L.2
Fleming, I.D.3
Fritz, A.4
Balch, C.M.5
Haller, D.G.6
-
29
-
-
0032879468
-
Prognosis of hepatocellular carcinoma: The BCLC staging classification
-
Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999;19:329-38.
-
(1999)
Semin Liver Dis
, vol.19
, pp. 329-338
-
-
Llovet, J.M.1
Bru, C.2
Bruix, J.3
-
30
-
-
0036189111
-
Prognostic prediction and treatment strategy in hepatocellular carcinoma
-
Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002;35:519-24.
-
(2002)
Hepatology
, vol.35
, pp. 519-524
-
-
Bruix, J.1
Llovet, J.M.2
-
31
-
-
0345299824
-
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
-
Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334: 693-700.
-
(1996)
N Engl J Med
, vol.334
, pp. 693-700
-
-
Mazzaferro, V.1
Regalia, E.2
Doci, R.3
Andreola, S.4
Pulvirenti, A.5
Bozzetti, F.6
-
33
-
-
0015854966
-
Transection of the oesophagus for bleeding oesophageal varices
-
Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-9.
-
(1973)
Br J Surg
, vol.60
, pp. 646-649
-
-
Pugh, R.N.1
Murray-Lyon, I.M.2
Dawson, J.L.3
Pietroni, M.C.4
Williams, R.5
-
34
-
-
64249101592
-
Automated immunoassay system for AFP-L3% using on-chip electrokinetic reaction and separation by affinity electrophoresis
-
Kagebayashi C, Yamaguchi I, Akinaga A, Kitano H, Yokoyama K, Satomura M, et al. Automated immunoassay system for AFP-L3% using on-chip electrokinetic reaction and separation by affinity electrophoresis. Anal Biochem 2009;388:306-11.
-
(2009)
Anal Biochem
, vol.388
, pp. 306-311
-
-
Kagebayashi, C.1
Yamaguchi, I.2
Akinaga, A.3
Kitano, H.4
Yokoyama, K.5
Satomura, M.6
-
35
-
-
0004509186
-
Regression using fractional polynomials of continuous covariates: Parsimonious parametric modelling
-
Royston P, Altman DG. Regression using fractional polynomials of continuous covariates: parsimonious parametric modelling. Applied Statistics 1994;43:429-67.
-
(1994)
Applied Statistics
, vol.43
, pp. 429-467
-
-
Royston, P.1
Altman, D.G.2
-
36
-
-
80052348326
-
Surveillance for hepatocellular carcinoma: In whom and how?
-
El-Serag HB, Davila JA. Surveillance for hepatocellular carcinoma: in whom and how? Therap Adv Gastroenterol 2011;4:5-10.
-
(2011)
Therap Adv Gastroenterol
, vol.4
, pp. 5-10
-
-
El-Serag, H.B.1
Davila, J.A.2
-
37
-
-
84866854645
-
Alpha-fetoprotein and novel tumor biomarkers as predictors of hepatocellular carcinoma recurrence after surgery: A brilliant star raises again
-
Lai Q, Melandro F, Pinheiro RS, Donfrancesco A, Fadel BA, Levi Sandri GB, et al. Alpha-fetoprotein and novel tumor biomarkers as predictors of hepatocellular carcinoma recurrence after surgery: a brilliant star raises again. Int J Hepatol 2012;2012:893103.
-
(2012)
Int J Hepatol
, vol.2012
, pp. 893103
-
-
Lai, Q.1
Melandro, F.2
Pinheiro, R.S.3
Donfrancesco, A.4
Fadel, B.A.5
Levi Sandri, G.B.6
-
38
-
-
77949659092
-
Serological surveillance for hepatocellular carcinoma: Time to quit
-
Sherman M. Serological surveillance for hepatocellular carcinoma: time to quit. J Hepatol 2010;52:614-5.
-
(2010)
J Hepatol
, vol.52
, pp. 614-615
-
-
Sherman, M.1
-
39
-
-
33947157637
-
The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: Evaluation in a United States referral population
-
quiz 267
-
Leerapun A, Suravarapu SV, Bida JP, Clark RJ, Sanders EL, Mettler TA, et al. The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population. Clin Gastroenterol Hepatol 2007;5:394-402; quiz 267.
-
(2007)
Clin Gastroenterol Hepatol
, vol.5
, pp. 394-402
-
-
Leerapun, A.1
Suravarapu, S.V.2
Bida, J.P.3
Clark, R.J.4
Sanders, E.L.5
Mettler, T.A.6
-
40
-
-
79954664197
-
Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alphafetoprotein < 20 ng/mL
-
Toyoda H, Kumada T, Tada T, Kaneoka Y, Maeda A, Kanke F, et al. Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alphafetoprotein < 20 ng/mL. Cancer Sci 2011;102:1025-31.
-
(2011)
Cancer Sci
, vol.102
, pp. 1025-1031
-
-
Toyoda, H.1
Kumada, T.2
Tada, T.3
Kaneoka, Y.4
Maeda, A.5
Kanke, F.6
-
41
-
-
34848886470
-
Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis
-
Sterling RK, Jeffers L, Gordon F, Sherman M, Venook AP, Reddy KR, et al. Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis. Am J Gastroenterol 2007;102: 2196-205.
-
(2007)
Am J Gastroenterol
, vol.102
, pp. 2196-2205
-
-
Sterling, R.K.1
Jeffers, L.2
Gordon, F.3
Sherman, M.4
Venook, A.P.5
Reddy, K.R.6
-
42
-
-
58049200257
-
Utility of Lens culinaris agglutinin-reactive fraction of alphafetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma
-
Sterling RK, Jeffers L, Gordon F, Venook AP, Reddy KR, Satomura S, et al. Utility of Lens culinaris agglutinin-reactive fraction of alphafetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma. Clin Gastroenterol Hepatol 2009;7:104-13.
-
(2009)
Clin Gastroenterol Hepatol
, vol.7
, pp. 104-113
-
-
Sterling, R.K.1
Jeffers, L.2
Gordon, F.3
Venook, A.P.4
Reddy, K.R.5
Satomura, S.6
-
43
-
-
47649105803
-
Role of tumor markers in assessment of tumor progression and prediction of outcomes in patients with hepatocellular carcinoma
-
Toyoda H, Kumada T, Osaki Y, Oka H, Kudo M. Role of tumor markers in assessment of tumor progression and prediction of outcomes in patients with hepatocellular carcinoma. Hepatol Res 2007;37 Suppl 2: S166-71.
-
(2007)
Hepatol Res
, vol.37
, Issue.SUPPL. 2
-
-
Toyoda, H.1
Kumada, T.2
Osaki, Y.3
Oka, H.4
Kudo, M.5
-
44
-
-
39849084412
-
Development of des-gamma-carboxy prothrombin (DCP) measuring reagent using the LiBASys clinical analyzer
-
Yamaguchi I, Nakamura K, Kitano H, Masuda Y, Kanke F, Kobatake S, et al. Development of des-gamma-carboxy prothrombin (DCP) measuring reagent using the LiBASys clinical analyzer. Clin Chem Lab Med 2008;46:411-6.
-
(2008)
Clin Chem Lab Med
, vol.46
, pp. 411-416
-
-
Yamaguchi, I.1
Nakamura, K.2
Kitano, H.3
Masuda, Y.4
Kanke, F.5
Kobatake, S.6
-
45
-
-
51849127949
-
Desgamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma
-
Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, et al. Desgamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol 2008;23:1541-8.
-
(2008)
J Gastroenterol Hepatol
, vol.23
, pp. 1541-1548
-
-
Durazo, F.A.1
Blatt, L.M.2
Corey, W.G.3
Lin, J.H.4
Han, S.5
Saab, S.6
-
46
-
-
33847231604
-
Clinical evaluation of lens culinaris agglutinin-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin in histologically proven hepatocellular carcinoma in the United States
-
Carr BI, Kanke F, Wise M, Satomura S. Clinical evaluation of lens culinaris agglutinin-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin in histologically proven hepatocellular carcinoma in the United States. Dig Dis Sci 2007;52:776-82.
-
(2007)
Dig Dis Sci
, vol.52
, pp. 776-782
-
-
Carr, B.I.1
Kanke, F.2
Wise, M.3
Satomura, S.4
-
47
-
-
67649305155
-
Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma
-
Marrero JA, Feng Z, Wang Y, Nguyen MH, Befeler AS, Roberts LR, et al. Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. Gastroenterology 2009;137:110-8.
-
(2009)
Gastroenterology
, vol.137
, pp. 110-118
-
-
Marrero, J.A.1
Feng, Z.2
Wang, Y.3
Nguyen, M.H.4
Befeler, A.S.5
Roberts, L.R.6
-
48
-
-
75449103932
-
Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma
-
Lok AS, Sterling RK, Everhart JE, Wright EC, Hoefs JC, Di Bisceglie AM, et al. Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma. Gastroenterology 2010;138:493-502.
-
(2010)
Gastroenterology
, vol.138
, pp. 493-502
-
-
Lok, A.S.1
Sterling, R.K.2
Everhart, J.E.3
Wright, E.C.4
Hoefs, J.C.5
Di Bisceglie, A.M.6
-
49
-
-
79959825606
-
Predictive value of tumor markers for hepatocarcinogenesis in patients with hepatitis C virus
-
Kumada T, Toyoda H, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, et al. Predictive value of tumor markers for hepatocarcinogenesis in patients with hepatitis C virus. J Gastroenterol 2011;46:536-44.
-
(2011)
J Gastroenterol
, vol.46
, pp. 536-544
-
-
Kumada, T.1
Toyoda, H.2
Kiriyama, S.3
Tanikawa, M.4
Hisanaga, Y.5
Kanamori, A.6
-
50
-
-
19544389853
-
Clinicopathologic features of patients with primary malignant hepatic tumors seropositive for alpha-fetoprotein-L3 alone in comparison with other patients seropositive for alpha-fetoprotein-L3
-
Okuda H, Saito A, Shiratori K, Yamamoto M, Takasaki K, Nakano M. Clinicopathologic features of patients with primary malignant hepatic tumors seropositive for alpha-fetoprotein-L3 alone in comparison with other patients seropositive for alpha-fetoprotein-L3. J Gastroenterol Hepatol 2005;20:759-64.
-
(2005)
J Gastroenterol Hepatol
, vol.20
, pp. 759-764
-
-
Okuda, H.1
Saito, A.2
Shiratori, K.3
Yamamoto, M.4
Takasaki, K.5
Nakano, M.6
-
51
-
-
18144411666
-
Updated treatment approach to hepatocellular carcinoma
-
Llovet JM. Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 2005;40:225-35.
-
(2005)
J Gastroenterol
, vol.40
, pp. 225-235
-
-
Llovet, J.M.1
-
52
-
-
2942577356
-
Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C
-
Lin OS, Keeffe EB, Sanders GD, Owens DK. Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C. Aliment Pharmacol Ther 2004;19:1159-72.
-
(2004)
Aliment Pharmacol Ther
, vol.19
, pp. 1159-1172
-
-
Lin, O.S.1
Keeffe, E.B.2
Sanders, G.D.3
Owens, D.K.4
-
53
-
-
3843125293
-
Randomized controlled trial of screening for hepatocellular carcinoma
-
Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004;130: 417-22.
-
(2004)
J Cancer Res Clin Oncol
, vol.130
, pp. 417-422
-
-
Zhang, B.H.1
Yang, B.H.2
Tang, Z.Y.3
|